Option program in Karo Bio (SE)

Carnegie acted as adviser to Karo Bio in the offer to all employees to receive stock options issued by Karo Bio. Karo Bio is a drug discovery company for the development of precision drugs to treat major diseases in the field of nuclear receptors.May, 2001.